AIDS: Crimean drug users at risk, says NGO

March 20, 2014

More than 14,000 injecting drug users in Crimea risk being cut off from life-saving treatment and services prohibited in Russia, an NGO working to halt HIV spread warned on Thursday.

Most immediately at risk are about 800 Crimeans who depend on opioid substitute therapy (OST), the International HIV/AIDS Alliance said in a statement highlighting a hidden health consequence of the political crisis.

People on OST receive synthetic drug substitutes which are safer than the heroin they replace and are administered under medical supervision, curbing HIV infection through needle-sharing.

"This treatment is prohibited in Russia and current stocks of methadone and buprenorphine on the Crimean peninsula will only last for another few weeks at most," said the alliance.

"With the blocking of highways that connect Crimea to the mainland, getting medical supplies through is challenging and there are concerns that a major public health crisis will arise as a result."

Once treatment is cut off, OST recipients will go into withdrawal and many are likely to revert to their old, unsafe drug habits, the British-based group said.

Contrary to Ukraine, where drug addicts have access to HIV prevention services like clean needle exchanges, condom distribution and HIV-testing, Russia takes a punitive approach to use that the alliance claimed was responsible for one of the highest rates of new HIV infections in the world.

"Injecting represent nearly 80 percent of all HIV cases in the country," said the statement.

OST has been available in Crimea for almost a decade under the political control of Ukraine, which saw the number of new HIV cases among people who inject drugs drop from 7,127 in 2006 to 5,847 last year.

Andriy Klepikov, executive direct of the alliance's Ukraine branch, urged Crimean authorities to intervene.

"Any interruption to harm reduction programming is a disaster for health, human rights and the HIV epidemic in the region," he said.

"We urge the authorities in Crimea to step in and ensure that critical supply chains are not disrupted and lives not put at risk as a result of territorial politicking."

Explore further: IAS urges Russian government to radically reassess counterproductive drug policies

Related Stories

Combination approach reduces spread of drug-related HIV

March 4, 2014

A computer model has created the most effective formula for reducing the spread of HIV among drug users in New York City over the next 25 years. Developed by scientists at Columbia University's Mailman School of Public Health ...

Recommended for you

Targeting HIV in semen to shut down AIDS

August 18, 2015

There may be two new ways to fight AIDS—using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection, according ...

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

Why HIV's cloak has a long tail

June 2, 2015

Virologists at Emory University School of Medicine, Yerkes National Primate Research Center, and Children's Healthcare of Atlanta have uncovered a critical detail explaining how HIV assembles its infectious yet stealthy clothing.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.